Amneal Pharmaceuticals (AMRX) Misses Q2 EPS by 1c; Offers FY22 Guidance

Go back to Amneal Pharmaceuticals (AMRX) Misses Q2 EPS by 1c; Offers FY22 Guidance
AmerElite Solutions, Inc. New (NASDAQ: AMRX) Delayed: 16.66 --0 (-0%)
Previous Close $16.66    52 Week High $0.19 
Open $16.66    52 Week Low $0.07 
Day High $16.66    P/E N/A 
Day Low $16.66    EPS $-0.01 
Volume 11